Author

Myung Chang Lee

GenentechORCID 0000-0002-7051-5822Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Barzin Y. NabetiD· 2 shared Alec E. DallasiD· 1 shared Alexandros P. DrainasiD· 1 shared Benjamin B. MorrisiD· 1 shared Carl Michael GayiD· 1 shared Catherine Allison StewartiD· 1 shared Clara L. PoupaultiD· 1 shared Darren R. TysoniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Barzin Y. NabetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 21, 2025

T CELLS promote the growth of small-cell lung carcinoma via an IL-6/CD74 axis

Maya Baron, Zoé Ginestet, Debadrita Bhattacharya…·Julien Sage

The paper shows T cells promote SCLC growth through an IL-6/CD74 axis, and IL-6 blockade enhances immunotherapy effectiveness in SCLC.

1 citation

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyMolecular CancerPeer-reviewedMar 20, 2025

DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer

Benjamin B. Morris, Simon Heeke, Yuanxin Xi…·Lauren A. Byers

This study identifies three distinct DDR phenotypes in SCLC associated with chemotherapy response and tumor evolution.

9 citations

humanbulk RNA-seq

𝕏 PostBluesky